Rockwell Medical, Innovative Renal Care Partner on Hemodialysis Product Continuity

Rockwell Medical Inc. is teaming up with Innovative Renal Care (IRC) to invest in high-quality hemodialysis products, streamline workflows, and help avoid potential supply chain disruptions.

“We are excited to partner with Rockwell Medical to reliably supply our clinics with hemodialysis concentrates,” IRC CEO David Doerr stated. “More efficient processes and supply chain continuity enables us to stay focused on achieving our company’s mission to deliver more tomorrows to our patients, their families, and friends.”

Under the terms of the multi-year agreement, Rockwell Medical will supply IRC with liquid and dry, acid and bicarbonate hemodialysis concentrates, as well as the DAMX45 dry acid concentrate mix system, which is U.S. Food and Drug Administration 510(k) approved to be used exclusively with Rockwell Medical’s CitraPure and Dri-Sate dry acid concentrate powders. This will enable IRC’s U.S. dialysis centers to reduce storage requirements while ensuring product quality and continuity. This multi-million dollar purchase agreement with utilization commitments will last three years and contains an option to extend an additional one-year period.

“IRC is a comprehensive renal care company paving the way for innovative solutions to treat and manage patients with, or at high-risk of, end-stage renal disease,” Rockwell Medical Senior Vice President/Chief Commercial Officer Tim Chole stated. “We are excited to expand our supply agreement with IRC and build upon our long-standing reputation for a reliable supply chain, high-quality products, and excellent customer service.”

Innovative Renal Care (IRC) partners with nephrologists and health systems to provide care for patients with chronic kidney disease and end-stage renal disease. Through joint ventures and an innovative, collaborative model, IRC empowers local care teams with the tools, technology, and support to deliver clinical outcomes and elevate the patient experience.

Rockwell Medical Inc. develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed in freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or a patient’s home. Rockwell Medical’s products are vital to vulnerable patients with end-stage kidney disease.